Correlated Immunohistochemical and Cytological Assays for the Prediction of Hematogenous Dissemination of Breast Cancer

Maja H. Oktay, Frank B. Gertler, Yi Fang Liu, Thomas E. Rohan, John S. Condeelis, Joan G. Jones

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Although metastasis is a major cause of death from breast cancer, our ability to predict which tumors will metastasize is limited (American Cancer Society 2010). Proper assessment of metastatic risk and elucidating the underlying mechanisms of metastasis will help personalize therapy and may provide insight into potential therapeutic targets. Traditionally, histologic grading, staging, hormone receptors, HER2/Neu, and proliferation assays have been the gold standard on which oncologists based their treatment decisions. However, all of these are indirect measures of metastatic risk. Recent insights from intravital imaging directly address questions of mechanism and have led to a new way of using histologic and cytologic material to assess metastatic risk. This review describes the tumor microenvironment model of invasion and intravasation, as well as an emerging histopathologic application based on this model. In particular, the authors describe a new immunohistochemical approach to the assessment of metastatic risk based on the density of intravasation microenvironment sites called the tumor microenvironment of metastasis. In addition, they describe an isoform assay for the actin regulatory protein Mena using fine needle aspiration samples and the details about how these 2 assays may be applied in clinical practice in a synergistic way to assess the risk of metastasis.

Original languageEnglish (US)
Pages (from-to)168-173
Number of pages6
JournalJournal of Histochemistry and Cytochemistry
Volume60
Issue number3
DOIs
StatePublished - Mar 2012

Fingerprint

Breast Neoplasms
Neoplasm Metastasis
Tumor Microenvironment
ErbB-2 Receptor
Fine Needle Biopsy
Actins
Cause of Death
Protein Isoforms
Therapeutics
Hormones
Neoplasms
Proteins
Oncologists
Intravital Microscopy

Keywords

  • breast cancer
  • fine needle aspiration (FNA) biopsy
  • immunohistochemical markers
  • metastasis
  • tumor microenvironment

ASJC Scopus subject areas

  • Anatomy
  • Histology
  • Medicine(all)

Cite this

Correlated Immunohistochemical and Cytological Assays for the Prediction of Hematogenous Dissemination of Breast Cancer. / Oktay, Maja H.; Gertler, Frank B.; Liu, Yi Fang; Rohan, Thomas E.; Condeelis, John S.; Jones, Joan G.

In: Journal of Histochemistry and Cytochemistry, Vol. 60, No. 3, 03.2012, p. 168-173.

Research output: Contribution to journalArticle

@article{7fe542dd85f74cef81d1c38b9e3535b2,
title = "Correlated Immunohistochemical and Cytological Assays for the Prediction of Hematogenous Dissemination of Breast Cancer",
abstract = "Although metastasis is a major cause of death from breast cancer, our ability to predict which tumors will metastasize is limited (American Cancer Society 2010). Proper assessment of metastatic risk and elucidating the underlying mechanisms of metastasis will help personalize therapy and may provide insight into potential therapeutic targets. Traditionally, histologic grading, staging, hormone receptors, HER2/Neu, and proliferation assays have been the gold standard on which oncologists based their treatment decisions. However, all of these are indirect measures of metastatic risk. Recent insights from intravital imaging directly address questions of mechanism and have led to a new way of using histologic and cytologic material to assess metastatic risk. This review describes the tumor microenvironment model of invasion and intravasation, as well as an emerging histopathologic application based on this model. In particular, the authors describe a new immunohistochemical approach to the assessment of metastatic risk based on the density of intravasation microenvironment sites called the tumor microenvironment of metastasis. In addition, they describe an isoform assay for the actin regulatory protein Mena using fine needle aspiration samples and the details about how these 2 assays may be applied in clinical practice in a synergistic way to assess the risk of metastasis.",
keywords = "breast cancer, fine needle aspiration (FNA) biopsy, immunohistochemical markers, metastasis, tumor microenvironment",
author = "Oktay, {Maja H.} and Gertler, {Frank B.} and Liu, {Yi Fang} and Rohan, {Thomas E.} and Condeelis, {John S.} and Jones, {Joan G.}",
year = "2012",
month = "3",
doi = "10.1369/0022155411435153",
language = "English (US)",
volume = "60",
pages = "168--173",
journal = "Journal of Histochemistry and Cytochemistry",
issn = "0022-1554",
publisher = "Histochemical Society Inc.",
number = "3",

}

TY - JOUR

T1 - Correlated Immunohistochemical and Cytological Assays for the Prediction of Hematogenous Dissemination of Breast Cancer

AU - Oktay, Maja H.

AU - Gertler, Frank B.

AU - Liu, Yi Fang

AU - Rohan, Thomas E.

AU - Condeelis, John S.

AU - Jones, Joan G.

PY - 2012/3

Y1 - 2012/3

N2 - Although metastasis is a major cause of death from breast cancer, our ability to predict which tumors will metastasize is limited (American Cancer Society 2010). Proper assessment of metastatic risk and elucidating the underlying mechanisms of metastasis will help personalize therapy and may provide insight into potential therapeutic targets. Traditionally, histologic grading, staging, hormone receptors, HER2/Neu, and proliferation assays have been the gold standard on which oncologists based their treatment decisions. However, all of these are indirect measures of metastatic risk. Recent insights from intravital imaging directly address questions of mechanism and have led to a new way of using histologic and cytologic material to assess metastatic risk. This review describes the tumor microenvironment model of invasion and intravasation, as well as an emerging histopathologic application based on this model. In particular, the authors describe a new immunohistochemical approach to the assessment of metastatic risk based on the density of intravasation microenvironment sites called the tumor microenvironment of metastasis. In addition, they describe an isoform assay for the actin regulatory protein Mena using fine needle aspiration samples and the details about how these 2 assays may be applied in clinical practice in a synergistic way to assess the risk of metastasis.

AB - Although metastasis is a major cause of death from breast cancer, our ability to predict which tumors will metastasize is limited (American Cancer Society 2010). Proper assessment of metastatic risk and elucidating the underlying mechanisms of metastasis will help personalize therapy and may provide insight into potential therapeutic targets. Traditionally, histologic grading, staging, hormone receptors, HER2/Neu, and proliferation assays have been the gold standard on which oncologists based their treatment decisions. However, all of these are indirect measures of metastatic risk. Recent insights from intravital imaging directly address questions of mechanism and have led to a new way of using histologic and cytologic material to assess metastatic risk. This review describes the tumor microenvironment model of invasion and intravasation, as well as an emerging histopathologic application based on this model. In particular, the authors describe a new immunohistochemical approach to the assessment of metastatic risk based on the density of intravasation microenvironment sites called the tumor microenvironment of metastasis. In addition, they describe an isoform assay for the actin regulatory protein Mena using fine needle aspiration samples and the details about how these 2 assays may be applied in clinical practice in a synergistic way to assess the risk of metastasis.

KW - breast cancer

KW - fine needle aspiration (FNA) biopsy

KW - immunohistochemical markers

KW - metastasis

KW - tumor microenvironment

UR - http://www.scopus.com/inward/record.url?scp=84859640858&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859640858&partnerID=8YFLogxK

U2 - 10.1369/0022155411435153

DO - 10.1369/0022155411435153

M3 - Article

VL - 60

SP - 168

EP - 173

JO - Journal of Histochemistry and Cytochemistry

JF - Journal of Histochemistry and Cytochemistry

SN - 0022-1554

IS - 3

ER -